International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers

Annals of Surgical Oncology

Volumn 20, Issue 12, 2013, Pages 3817-3822

  Semple, John ^a   Metcalfe, Kelly A ^a,b   Lynch, Henry T ^c   Kim Sing, Charmaine ^d   Senter, Leigha ^e   Pal, Tuya ^f   Ainsworth, Peter ^g   Lubinski, Jan ^h   Tung, Nadine ⁱ   Eng, Charis ^j,k,l,m   Gilchrist, Donna ⁿ   Blum, Joanne ^o   Neuhausen, Susan L ^p   Singer, Christian F ^q   Ghadirian, Parviz ^r   Sun, Ping ^a   Narod, Steven A ^a  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e OHIO STATE UNIVERSITY   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g LONDON REGIONAL CANCER PROGRAM   (Canada)

^h POMERANIAN MEDICAL UNIVERSITY   (Poland)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j Genomic Medicine Institute and Center for Personalized Genetic Healthcare   (United States)

^k TAUSSIG CANCER INSTITUTE   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF ALBERTA   (Canada)

^o BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^p CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^q MEDICAL UNIVERSITY OF VIENNA   (Austria)

^r UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER PREVENTION; CHINA; FEMALE; FRANCE; GENE MUTATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL HISTORY; NORWAY; PARTIAL MASTECTOMY; QUESTIONNAIRE; UNITED STATES;

ADULT; AGE FACTORS; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CANADA; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; INTERNATIONAL AGENCIES; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROGNOSIS; YOUNG ADULT;

EID: 84886102161     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3040-4     Document Type: Article

References (25)

1. Antoniou AC, Shenton A, Maher ER, et al. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2006;8:R72.
2. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329-33.
3. Metcalfe K, Gershman S, Lynch HT, et al. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2011;104:1384-92.
4. Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22:2328-35.
5. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633-7.
6. Alderman AK, Hawley ST, Janz NK, et al. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population-based study. J Clin Oncol. 2009;27:5325-30.
7. Hall SE, Holman CDcInequalities in breast cancer reconstructive surgery according to social and locational status in Western Australia. Eur J Surg Oncol. 2003;29:519-25.
8. Hvilsom GB, Holmich LR, Frederiksen K, et al. Socioeconomic position and breast reconstruction in Danish women. Acta Oncol. 2011;50:265-73.
9. Jeevan R, Cromwell DA, Browne JP, et al. Regional variation in use of immediate breast reconstruction after mastectomy for breast cancer in England. Eur J Surg Oncol. 2010;36:750-5.
10. Yu KD, Di GH, Wu J, et al. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Ann Surg Oncol. 2007;14:2502-9.
11. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2008;122:2017-22.
12. Metcalfe KA, Snyder C, Seidel J, et al. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer. 2005;4:97-103.
13. Baxter N, Goel V, Semple JL. Rates and regional variation of breast reconstruction following mastectomy for breast cancer: viewpoint from a single payer medical system. 2002.
14. Polednak AP. Postmastectomy breast reconstruction in Connecticut: trends and predictors. Plast Reconstr Surg. 1999;104:669-73.
15. Alderman AK, McMahon L Jr, Wilkins EG. The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg. 2003;111:695-703.
16. Polednak AP. How frequent is postmastectomy breast reconstructive surgery? A study linking two statewide databases. Plast Reconstr Surg. 2001;108:73-7.
17. Alderman AK, Wei Y, Birkmeyer JD. Use of breast reconstruction after mastectomy following the Women's Health and Cancer Rights Act. JAMA. 2006;295:387-8.
18. Joslyn SA. Patterns of care for immediate and early delayed breast reconstruction following mastectomy. Plast Reconstr Surg. 2005;115:1289-96.
19. Rosson GD, Singh NK, Ahuja N, et al. Multilevel analysis of the impact of community vs patient factors on access to immediate breast reconstruction following mastectomy in Maryland. Arch Surg. 2008;143:1076-81.
20. Tseng WH, Stevenson TR, Canter RJ, et al. Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg. 2010;126:1815-24.
21. Kruper L, Holt A, Xu XX, et al. Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Ann Surg Oncol. 2011;18:2158-65.
22. Morrow M, Scott SK, Menck HR, et al. Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Data Base study. J Am Coll Surg. 2001;192:1-8.
23. Tseng JF, Kronowitz SJ, Sun CC, et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004;101:1514-23.
24. Metcalfe KA, Goel V, Lickley L, et al. Prophylactic bilateral mastectomy: patterns of practice. Cancer. 2002;95:236-42.
25. Metcalfe KA, Lubinski J, Ghadirian P, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol. 2008;26:1093-7.